Skip to content
DraconiticResearch
Search Sources API
201,683 studies31 sourcesUpdated 51 min ago
Peer-reviewedCC BY-NC-NDInflammation

Neuroprotective Mechanisms of Sinomenine in Ischemic Stroke: The Role of Fermt2 in Neuroinflammation.

  1. 1Department of Neurology, The Second Affiliated Hospital of Hunan, University of Chinese Medicine, Changsha, Hunan, 410005, China.
  2. 2Department of Neurology, The Second Affiliated Hospital of Hunan, University of Chinese Medicine, Changsha, Hunan, 410005, China. [email protected].

Abstract

Sinomenine (SIN) has been established to exert neuroprotective effects in ischemic stroke (IS), yet its specific molecular targets and detailed mechanisms remain incompletely understood. This study identified Fermt2 as a critical target through which SIN exerted its neuroprotective effects in IS. In a rat model of cerebral ischemia-reperfusion injury, overexpression of Fermt2 improved neurological deficits, reduced cerebral infarct volume by nearly one-third, and significantly decreased neuronal apoptosis in the ischemic penumbra. In vitro and in vivo experiments demonstrated that upregulation of Fermt2 promoted a shift in microglial polarization from the pro-inflammatory M1 phenotype to the anti-inflammatory M2 phenotype, thereby suppressing pro-inflammatory cytokines and restoring anti-inflammatory factors. Mechanistic investigations revealed that Fermt2 functioned by inhibiting the RhoA/ROCK/NF-κB signaling pathway. Crucially, knockdown of Fermt2 reversed the beneficial effects of SIN in IS rats. In conclusion, Fermt2 is a master regulator of microglia-dependent neuroinflammation and a promising therapeutic target for IS.

Related

  1. Novel adamantane-nitrone hybrids: design, synthesis, and their multi-target neuroprotective effects against ischemic stroke
    Hao Lu, Jiaxin Zheng, Ningning Luo +6
    Frontiers in PharmacologyPeer-reviewedCC BY 4.0Full textNeurologyCrossrefEurope PMCPMCEurope PMC
  2. Benefit Expectations and Neuroprotective Prescribing for Acute Ischemic Stroke in China
    Z. Tan, L. Liu, A. Wang +6
    medRxivPreprintCC BY-NC-NDFull textNeurologymedRxiv
  3. A multi-dimensional comparative evaluation of ten injectable neuroprotective agents for acute ischemic stroke based on the Chinese guideline for drug selection
    Zhisheng Yao, Yuxin Zhang, Hui Bai +3
    Frontiers in PharmacologyPeer-reviewedCC BY 4.0Full textNeurologyCrossref
  4. Herbal-derived bioactive compounds in stroke recovery: from neuroprotective mechanisms to clinical evidence and translational challenges
    Xi-zhe Sun, Jia-lu Lv, Lan-xin Gu +4
    Frontiers in NeurologyPeer-reviewedCC BY 4.0Full textNeurologyCrossrefEurope PMCPMC
  5. Synergistic regulation of neuroinflammation by mitophagy and the cGAS–STING pathway following ischemic stroke
    Yu Xiao, Yu Xiao, Peijie Fu +14
    Frontiers in Molecular NeurosciencePeer-reviewedCC BYFull textNeurologyDOAJ
BibTeX
@article{yan2026neuroprotective,
  title = {{Neuroprotective Mechanisms of Sinomenine in Ischemic Stroke: The Role of Fermt2 in Neuroinflammation.}},
  author = {Jie Yan and Wenjuan Li and Tian Qin and Haimin Ye and Congling Chen and Ling Li and Yehui Liu},
  journal = {Inflammation},
  year = {2026},
  month = aug,
  doi = {10.1007/s10753-026-02556-w},
  url = {https://europepmc.org/article/MED/42967958},
  note = {CC BY-NC-ND},
}
RIS
TY  - JOUR
TI  - Neuroprotective Mechanisms of Sinomenine in Ischemic Stroke: The Role of Fermt2 in Neuroinflammation.
AU  - Jie Yan
AU  - Wenjuan Li
AU  - Tian Qin
AU  - Haimin Ye
AU  - Congling Chen
AU  - Ling Li
AU  - Yehui Liu
PY  - 2026
DA  - 2026/08/05
JO  - Inflammation
DO  - 10.1007/s10753-026-02556-w
UR  - https://europepmc.org/article/MED/42967958
AB  - Sinomenine (SIN) has been established to exert neuroprotective effects in ischemic stroke (IS), yet its specific molecular targets and detailed mechanisms remain incompletely understood. This study identified Fermt2 as a critical target through which SIN exerted its neuroprotective effects in IS. In a rat model of cerebral ischemia-reperfusion injury, overexpression of Fermt2 improved neurological deficits, reduced cerebral infarct volume by nearly one-third, and significantly decreased neuronal apoptosis in the ischemic penumbra. In vitro and in vivo experiments demonstrated that upregulation of Fermt2 promoted a shift in microglial polarization from the pro-inflammatory M1 phenotype to the anti-inflammatory M2 phenotype, thereby suppressing pro-inflammatory cytokines and restoring anti-inflammatory factors. Mechanistic investigations revealed that Fermt2 functioned by inhibiting the RhoA/ROCK/NF-κB signaling pathway. Crucially, knockdown of Fermt2 reversed the beneficial effects of SIN in IS rats. In conclusion, Fermt2 is a master regulator of microglia-dependent neuroinflammation and a promising therapeutic target for IS.
SN  - 0360-3997
SN  - 1573-2576
ER  -